Nymox Pharmaceutical Corporation Gains 38.89%
Fri, Jul 15, 2022 at 08:21 PM
Nymox Pharmaceutical Corporation (NYMX:NASDAQ) soared at $0.3, representing a gain of 38.9%. From Fri, Jul 01, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
About Nymox Pharmaceutical Corporation (NYMX:NASDAQ)
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Top 10 Gainers:
- United Maritime Corporation (USEA:NASDAQ), 175.91%
- Vertical Aerospace Ltd. (EVTL:NYSE), 72.41%
- ITHAX Acquisition Corp. (ITHX:NASDAQ), 40.6%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 38.89%
- Vigil Neuroscience Inc. (VIGL:NASDAQ), 31.56%
- Cemtrex, Inc. (CETX:NASDAQ), 30.71%
- Auddia Inc. (AUUD:NASDAQ), 30%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 28.3%
- NexImmune Inc. (NEXI:NASDAQ), 24.49%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 24.35%